Recent Updates
Recently added Catalysts
ZLAB

Zai Lab Announces Pricing of Public Offering of American Depositary Shares and Ordinary Shares

Key Takeaway: Zai Lab Announces Pricing of Public Offering of American Depositary Shares and Ordinary Shares

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+60%
120-day peak, hindsight
Typical move
2.2%
average across 15 past catalysts
Cash runway
~28 mo
Low dilution risk
Lead asset
ZL-1310
Phase 3 · Small-cell Lung Cancer

Full Press Release Details

Zai Lab Announces Pricing of Public Offering of American Depositary Shares and Ordinary Shares.
Last updated: Apr 20, 2021